Which kidney function tests do people with high blood pressure need?
Short answer: Most kidney assessments for people with high blood pressure include a blood creatinine test with estimated glomerular filtration rate, or eGFR, and a urine albumin-to-creatinine ratio, or UACR. Together, these assess kidney filtration and look for evidence of kidney damage.
- Evidence: KDIGO recommends assessing people at risk of chronic kidney disease with both a measure of filtration and urine albumin testing.
- Exceptions: Your healthcare provider may add cystatin C, electrolytes, urinalysis, or imaging depending on your history and results.
- Sample type: Typically venous blood for creatinine and a spot urine sample for UACR.
- Relevant test: The GetTested Kidney Function Test is a relevant product to review. Confirm its current biomarker list, whether eGFR is reported, and collection requirements; do not assume it includes urine albumin testing.
- Medical source: KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.
High blood pressure, also called hypertension, can affect the kidneys before noticeable symptoms develop. Testing is therefore based on risk, not simply on whether you feel unwell.
A useful assessment answers two different questions: are the kidneys filtering blood adequately, and are their filters leaking albumin, a blood protein? A blood test alone does not fully answer both.
This article is informational and is not a substitute for professional medical advice. Discuss test selection and results with a licensed healthcare provider.
Why does high blood pressure affect the kidneys?
Short answer: Persistent high blood pressure can damage the small blood vessels and filters inside the kidneys. Kidney disease can also raise blood pressure, creating a two-way relationship.
- Evidence: NIDDK explains that high blood pressure can narrow and damage blood vessels, reducing the kidneys’ ability to work properly.
- Exceptions: Not everyone with hypertension develops kidney disease, and an abnormal kidney result is not automatically caused by high blood pressure.
- Sample type: Blood and urine tests assess kidney effects; blood pressure itself is measured with a cuff.
- Medical source: NIDDK: High Blood Pressure & Kidney Disease.
Your kidneys filter waste and excess fluid from the blood. They also help regulate blood pressure through fluid balance and hormone signaling. Damage to their blood vessels can interfere with these functions.
When the kidneys cannot remove excess fluid effectively, the resulting fluid buildup can further increase blood pressure. This helps explain why clinicians consider blood pressure and kidney health together rather than as separate issues.
Risk depends on several factors, including how long hypertension has been present, its severity, diabetes, cardiovascular disease, and family history. Early chronic kidney disease often causes no symptoms. Normal-looking urine and an absence of pain do not establish that kidney function is normal.
Which blood tests check kidney function?
Short answer: Creatinine with eGFR is the main starting point; cystatin C can improve the estimate when needed. Blood urea nitrogen and electrolytes provide additional information but do not replace eGFR and urine albumin testing.
- Evidence: KDIGO recommends creatinine-based eGFR initially and supports using creatinine plus cystatin C when available to improve assessment, particularly when greater accuracy matters.
- Exceptions: Creatinine may be misleading with very low or high muscle mass, and eGFR is less reliable when kidney function is changing rapidly.
- Sample type: Usually venous blood. Collection methods for home services vary and must be checked against the specific test instructions.
- Relevant test: Review the Kidney Function Test for its included measurements. Cystatin C and electrolytes should not be assumed to be included.
- Medical source: KDIGO 2024 CKD Guideline.
Creatinine: This waste product comes mainly from normal muscle metabolism. The kidneys remove it from the blood. A higher concentration can indicate reduced filtration, but muscle mass, recent meat intake, intense exercise, and certain medications can also influence the result.
eGFR: This is a calculated estimate, not a separately measured substance. Adult equations use creatinine, age, and sex; some also use cystatin C. Current recommended U.S. equations do not include a race adjustment. eGFR is usually reported in mL/min/1.73 m².
Cystatin C: This protein offers another way to estimate filtration and is generally less affected by muscle mass. However, it is not free of limitations: inflammation, thyroid dysfunction, and certain medications can affect it. A combined creatinine–cystatin C estimate is often more informative than either marker alone.
Blood urea nitrogen, or BUN: This measures a waste product related to protein breakdown. Hydration, protein intake, gastrointestinal bleeding, and other factors can change BUN, so it is not a stand-alone measure of kidney function.
Potassium, sodium, and bicarbonate: These help assess electrolyte and acid–base balance. They are especially relevant when kidney disease or medication-related effects are a concern.
Why is a urine albumin test important if blood results are normal?
Short answer: Albumin can leak into urine before eGFR falls. UACR therefore helps identify kidney damage that a creatinine blood test alone may miss.
- Evidence: KDIGO assesses kidney risk using both eGFR and albuminuria because they provide complementary information.
- Exceptions: Exercise, urinary infection, menstrual contamination, and other temporary factors can raise urine albumin, so an unexpected result usually needs confirmation.
- Sample type: A spot urine sample; a first-morning sample is preferred when feasible, especially for confirmation.
- Medical source: NIDDK: Chronic Kidney Disease Tests & Diagnosis.
UACR compares the amount of albumin in urine with urine creatinine. The ratio helps account for how concentrated or diluted the sample is. It is different from the creatinine measurement used to calculate blood-based eGFR.
Common UACR categories are:
- Below 30 mg/g: Normal to mildly increased albuminuria.
- 30–300 mg/g: Moderately increased albuminuria.
- Above 300 mg/g: Severely increased albuminuria.
A routine urine dipstick is not equivalent to a quantitative UACR and can miss smaller increases in albumin. A 24-hour urine collection is usually unnecessary for an initial albumin assessment.
If a home blood panel does not include urine testing, ask your provider whether a separate UACR is appropriate. A reassuring eGFR does not eliminate that question.
How often should people with hypertension test kidney function?
Short answer: Kidney testing is generally part of the initial hypertension evaluation, with repeat testing based on results, medications, and individual risk. For established chronic kidney disease, KDIGO recommends checking eGFR and albuminuria at least annually, and more often when risk is higher.
- Evidence: KDIGO specifies at least annual assessment for people with CKD, with more frequent monitoring when results could affect clinical decisions.
- Exceptions: There is no single testing interval that fits everyone with hypertension but no CKD. Acute illness, abnormal results, and medication changes may require earlier testing.
- Sample type: Blood for creatinine/eGFR and relevant electrolytes; urine for UACR.
- Medical source: KDIGO 2024 CKD Guideline; NIDDK: CKD Tests & Diagnosis.
A practical discussion with your provider can follow these situations:
- Newly identified hypertension: Establish baseline kidney measurements and determine whether urine albumin assessment is needed.
- Stable hypertension without known CKD: An annual review is a reasonable point to discuss repeat testing, but the actual interval should be individualized.
- Known CKD: Testing may be needed several times per year when eGFR is lower, albuminuria is higher, or results are changing.
- New abnormal result: Confirmation may be needed sooner than the routine monitoring date.
- Medication monitoring: For people with CKD, KDIGO recommends checking creatinine and potassium within 2–4 weeks after an ACE inhibitor or ARB is started or its dose increased, depending on baseline kidney function and potassium.
That medication-monitoring example is not a universal schedule for every blood pressure medicine. Your prescriber determines the appropriate timing. Do not start, stop, or change medication based on a home result without medical guidance.
What do eGFR results mean, and does one abnormal result mean kidney disease?
Short answer: A lower eGFR generally indicates lower estimated filtration, but one result does not establish chronic kidney disease. CKD requires evidence of kidney abnormalities lasting at least three months.
- Evidence: KDIGO defines CKD by persistent abnormalities of kidney structure or function and classifies risk using both eGFR and albuminuria.
- Exceptions: A sudden decline can represent an acute problem and may need prompt assessment; clinicians do not wait three months when acute kidney injury is suspected.
- Sample type: Blood for eGFR calculation, paired with urine albumin testing and other assessment when indicated.
- Medical source: KDIGO 2024 CKD Guideline.
The standard eGFR categories are:
- 90 or higher: G1, normal or high filtration.
- 60–89: G2, mildly decreased filtration.
- 45–59: G3a, mildly to moderately decreased filtration.
- 30–44: G3b, moderately to severely decreased filtration.
- 15–29: G4, severely decreased filtration.
- Below 15: G5, the kidney failure category when chronic.
An eGFR of 60–89 does not, by itself, establish CKD. Other evidence, such as persistent albuminuria or structural abnormalities, is needed. Conversely, an eGFR of 90 or higher does not rule out kidney disease when other evidence of damage is present.
An eGFR below 60 persisting for at least three months can meet a CKD criterion. Interpretation still requires clinical context, including age, prior results, recent illness, and possible limitations of the estimating equation.
Trends matter more than an isolated label. A small fluctuation may reflect ordinary variability, while a sustained decline warrants investigation. eGFR is an estimate of filtration, not a percentage of kidney function.
How should you prepare for a kidney function test?
Short answer: Follow the laboratory’s instructions and tell your provider about recent illness, strenuous exercise, medicines, and supplements. Fasting is not universally required, although another measurement in the same panel may require it.
- Evidence: KDIGO recognizes dietary intake, muscle-related factors, and non-kidney influences as potential limitations of creatinine-based estimates.
- Exceptions: Preparation differs by panel and collection method; a combined metabolic panel may have different instructions from an isolated creatinine test.
- Sample type: Blood for kidney biomarkers; a separate urine sample for UACR.
- Medical source: KDIGO 2024 CKD Guideline.
Report vomiting, diarrhea, fever, or reduced fluid intake because these can affect interpretation. Recent intense exercise, a large meat meal, or creatine supplement use may also influence creatinine.
Do not deliberately overhydrate to try to improve a result. If you have a prescribed fluid restriction, follow your existing clinical instructions rather than generic collection advice.
For UACR, mention urinary symptoms, menstruation, and recent strenuous exercise. Your provider may recommend a repeat sample when a temporary influence has passed. Do not stop prescribed medicines or supplements for testing unless your healthcare provider specifically instructs you to do so.
Can an at-home kidney function test replace a clinical evaluation?
Short answer: No. At-home testing can provide measurements for review, but it does not screen for kidney disease or replace a clinician’s assessment of blood pressure, medical history, urine findings, and result trends.
- Evidence: FDA guidance emphasizes following home-test instructions and discussing results with a healthcare provider.
- Exceptions: Home testing is not an appropriate substitute for urgent assessment when someone is acutely unwell or has concerning symptoms.
- Sample type: Product-specific; confirm whether collection uses finger-prick blood, venous blood, or another method rather than assuming from the product name.
- Relevant test: The GetTested Kidney Function Test is analyzed in a CLIA-certified, CAP-accredited laboratory. Check the current product information for included biomarkers and collection details.
- Medical source: FDA: Home Use Tests.
Laboratory certification applies to the laboratory, not to the test, and does not establish that every result will be error-free. Collection quality, shipping conditions, the analytical method, and biological variability can all affect results.
Before ordering, check whether eGFR is reported, whether urine albumin needs separate testing, and how abnormal results are communicated. Direct-to-consumer testing availability varies by state; do not assume every service is available everywhere.
Bring prior results, your medication list, and recent blood pressure readings to the follow-up discussion. Those details help your provider decide whether a result represents a stable baseline, a temporary change, or a finding that needs further evaluation.
What should you do after an abnormal kidney test result?
Short answer: Discuss the result with a licensed healthcare provider, who can assess its significance and arrange appropriate confirmation. Seek prompt medical assessment for a sudden major change or symptoms such as markedly reduced urination or new shortness of breath.
- Evidence: KDIGO recommends confirming incidental low eGFR or elevated albuminuria and evaluating possible causes rather than assuming chronic disease from one sample.
- Exceptions: Critical electrolyte results, suspected acute kidney injury, or severe symptoms may need immediate attention rather than routine repeat testing.
- Sample type: Repeat blood and urine testing may be needed; imaging or specialist assessment depends on the findings.
- Medical source: KDIGO 2024 CKD Guideline.
Useful questions include: How does this compare with my previous results? Was UACR measured? Could illness or another factor explain the change? When should testing be repeated? Would cystatin C or a kidney specialist’s assessment help?
The central message is straightforward: with hypertension, kidney monitoring works best when it combines eGFR, urine albumin, and changes over time. A home measurement can contribute information, but a clinician provides the interpretation and diagnosis.




